Femasys (FEMY) Change in Accured Expenses (2020 - 2026)
Femasys (FEMY) reported Change in Accured Expenses of -$193226.0 for Q1 2026, down 1179.13% on a YoY basis from $17905.7 in Q1 2025, and down 294.37% quarter-over-quarter from $99410.0 in Q4 2025.
Femasys (FEMY) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Femasys has reported Change in Accured Expenses for 7 years, with the latest figure at -$193226.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses fell 1179.13% year-over-year to -$193226.0; the trailing twelve-month figure through Mar 2026 stood at -$201298.0 (down 127.18% YoY), and the FY2025 full-year result was -$23178.0, up 36.62% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$193226.0, down from $99410.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $874854.0 in Q4 2023, with the low at -$792239.0 in Q1 2024.
- Historically, Change in Accured Expenses has averaged $34561.0 across 5 years, with a median of -$7335.0 in 2022.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses slumped 2062.18% — and 2024, when it soared 53161.29%.
- Femasys' Change in Accured Expenses stood at -$116377.0 in 2022, then surged by 851.74% to $874854.0 in 2023, then tumbled by 67.99% to $280083.0 in 2024, then tumbled by 64.51% to $99410.0 in 2025, then tumbled by 294.37% to -$193226.0 in 2026.
- The last three Change in Accured Expenses figures came in at -$193226.0 (Q1 2026), $99410.0 (Q4 2025), and -$24291.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -284.70 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -32.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 103.88 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -151.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 5.38 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 203.00 Mn |
| 10 | Femasys | 254.59 Mn | 249.20 Mn | - | -193,226.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -193,226.00 |
| Mar 31, 2026 | -193,226.00 |
| Dec 31, 2025 | 99,410.00 |
| Dec 31, 2025 | 99,410.00 |
| Sep 30, 2025 | -24,291.00 |
| Sep 30, 2025 | -24,291.00 |
| Jun 30, 2025 | -83,191.00 |
| Jun 30, 2025 | -83,191.00 |
| Mar 31, 2025 | -15,106.00 |
| Mar 31, 2025 | -15,106.00 |
| Dec 31, 2024 | 280,083.00 |
| Dec 31, 2024 | 280,083.00 |
| Sep 30, 2024 | -276,994.00 |
| Sep 30, 2024 | -276,994.00 |
| Jun 30, 2024 | 752,582.00 |
| Jun 30, 2024 | 752,582.00 |
| Mar 31, 2024 | -792,239.00 |
| Mar 31, 2024 | -792,239.00 |
| Dec 31, 2023 | 874,854.00 |
| Dec 31, 2023 | 874,854.00 |